CAH-301
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAH-301, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])